Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Diabetologia 52 , S60 (2009)
Patients are welcome to participate in the tailoring process as we customize therapies
D.NadeemM
Outcome The primary outcome was to assess the incidence of new-onset adverse CVEs, which were categorised as: (1) heart failure
Galectin-3 activates PPAR and supports white adipose tissue formation and high-fat diet-induced obesity
US$ 26.70
US$ 22.55
US$ 27.50
US$ 22.13
